An ELISA test for detecting chloroquine in urine

Area of Science:

• Analytical Chemistry
• Immunology
• Pharmacology

Background:

• Chloroquine is a vital antimalarial drug.
• Accurate monitoring of chloroquine levels is crucial for treatment efficacy and preventing resistance.
• Existing diagnostic methods for chloroquine detection may have limitations.

Purpose of the Study:

• To develop and validate novel enzyme-linked immunosorbent assays (ELISA) for detecting chloroquine in urine.
• To assess the sensitivity, specificity, and cross-reactivity of the developed ELISA tests.
• To compare the performance of the ELISA tests against established colorimetric methods in a field setting.

Main Methods:

• Development of two ELISA tests utilizing polyclonal and monoclonal antibodies.
• Antibodies designed to target the 7-chloro-4-amino-quinoline core structure of chloroquine.
• Testing for cross-reactivity with other antimalarial drugs.
• Field trial comparing ELISA performance against Dill Glazko and Haskins colorimetric tests.

Main Results:

• The developed ELISA tests demonstrated high sensitivity and specificity for chloroquine detection.
• No significant cross-reactivity was observed with other common antimalarials.
• The chloroquine ELISA outperformed Dill Glazko and Haskins colorimetric tests in a field trial.
• A small percentage of false positive results were noted at a 1:10 urine dilution, but not at higher dilutions.

Conclusions:

• The developed ELISA tests provide a sensitive and specific method for detecting chloroquine and its metabolites in urine.
• These novel assays offer a superior alternative to existing colorimetric tests for routine monitoring.
• Further validation at higher dilutions is recommended to mitigate potential false positives.